Evidence map›Paper›PMID 26891053›Full record

ArticleAmerican journal of nephrology2016

Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease.

Sankar D Navaneethan, Jesse D Schold, Haiquan Huang, Georges Nakhoul, Stacey E Jolly, Susana Arrigain, Raed A Dweik, Joseph V Nally

Abstract read
In one paragraph

Article in American journal of nephrology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Observational
  5. Article
  6. Soft tissue calcifications in chronic kidney disease-beyond the vasculature.Pflugers Archiv : European journal of physiology · 2025
    Review
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Clinical characteristics of severe coronavirus disease 2019 patients with chronic obstructive pulmonary disease.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  12. Lung-kidney interactions and their role in chronic kidney disease-associated pulmonary diseases.American journal of physiology. Lung cellular and molecular physiology · 2022
    Review
  13. Gender dimension in cardio-pulmonary continuum.Frontiers in cardiovascular medicine · 2022
    Review
  14. Article
  15. Observational
  16. Review
  17. Diagnosis and Management of Pulmonary Hypertension in Patients With CKD.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sankar D NavaneethanSelzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Tex., USA.
Jesse D Schold
Haiquan Huang
Georges Nakhoul
Stacey E Jolly
Susana Arrigain
Raed A Dweik
Joseph V Nally

Funding

Visceral Adiposity and Physical Fitness in CKDR01DK101500 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI NAVANEETHAN, SANKAR DASS · 2014 to 2018
$3.0M
Chronic Kidney Disease Knowledge and Awareness among American IndiansK23DK091363 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI JOLLY, STACEY · 2011 to 2015
$796k
Navigating the Challenges of Chronic Kidney DiseaseR34DK094112 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI NALLY, JOSEPH · 2011 to 2013
$700k
NIDDK NIH HHS DK094112NIDDK NIH HHS K23 DK091363NIDDK NIH HHS K23DK091363NIDDK NIH HHS R01 DK101500NIDDK NIH HHS R01DK101500NIDDK NIH HHS R34 DK094112
6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) is associated with higher mortality in the general population. We studied the associations between COPD and death among chronic kidney disease (CKD) patients along with reporting cause-specific death data.

methodsWe included 56,960 patients with stages 3 and 4 CKD who were followed in a large health care system. Associations between COPD and all-cause mortality and various causes of death (respiratory deaths, cardiovascular deaths, malignancy-related deaths and deaths due to other reasons) were studied using the Cox proportional hazards and competing risk models.

resultsOut of 56,960 CKD patients, 4.7% (n = 2,667) had underlying COPD. Old age, presence of diabetes, hypertension, coronary artery disease, congestive heart failure, and smoking were associated with higher risk for COPD. During a median follow-up of 3.7 years, 15,969 patients died. After covariate adjustment, COPD was associated with a 41% increased risk (95% CI 1.31-1.52) for all-cause mortality, and fourfold increased risk (sub-hazard ratio 4.36, 95% CI 3.54-5.37) for respiratory-related deaths. In a sensitivity analysis that was performed by defining COPD as the use of relevant International Classification of Diseases-9 codes and medications used to treat COPD, similar results were noted.

conclusionsCOPD is associated with higher risk for death among those with CKD, and an underlying lung disease accounts for significant proportion of deaths. These data highlight the need for further prospective studies to understand the underlying mechanisms and potential interventions to improve outcomes in this population.

Indexed as

Cause of DeathAgedAged, 80 and overAge FactorsComorbidityCoronary DiseaseDiabetes MellitusFemaleFollow-Up StudiesHeart FailureHumansHypertensionMaleMiddle AgedOhioProportional Hazards Models

Identifiers

PMID26891053
PMCPMC4794258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.